TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Hearing threshold in the extended high-frequency range
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in M-protein levels in serum/urine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Loss of graft
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Cyclosporine/tacrolimus bioavailability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effectiveness of needle placement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Fugyl-meyer motor assessment scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: regional brain uptake of [18F]T807
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: standardized uptake value ratio (SUVr)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: False negative rate of vacuum-assisted biopsy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite outcome of multiple cardiovascular risk factors
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change From Baseline in Levodopa-induced Dyskinesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Maximum tolerated dose of SBRT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of Clinical Global Improvement (CGI)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Cumulative Intraoperative Hypotension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Survival time without needs of a ventilator
Endpoint domain: Mortality/survival
Primary endpoint: Dyspnea in daily living
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Recurrence, Progression or Death
Endpoint domain: Mortality/survival
Primary endpoint: Clinical presentation and disease course
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Serum Phosphate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Sustained Virologic Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Improvement of posture, balance and gait disturbance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Liver Histological improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Systolic and diastolic blood pressures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Accuracy in distinguishing high-grade neoplasia from non-high-grade neoplasia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Sensitivity in distinguishing high-grade neoplasia from non-high-grade neoplasia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Specificity in distinguishing high-grade neoplasia from non-high-grade neoplasia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change from baseline in Total Serum Thyroxine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Volume loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Treatment patterns
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Drug utilization
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Healthcare resource utilization
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Proportion of subjects responsive to serotypes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Limb function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Labial bone changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Percentage of Participants With Clinical Remission at Week 14
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants With Endoscopic Improvement at Week 14
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants With Clinical Remission at Week 66
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants With Endoscopic Improvement at Week 66
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Absolute Change in Absolute Time Spent 'Off'
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subjective Satiety
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Post Anesthesia Care Unit Length of Stay
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Delayed nausea
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Treatment response rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Normalization of B-cell lymphoma 2 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Auditory Hallucination Rating Scale (AHRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Questionnaire for Psychotic Experiences (QPE)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Hallucinations App
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Hallucination Change Scale (HCS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite Endpoint of Cardiovascular Events
Endpoint domain: Mortality/survival
Primary endpoint: Endurance walk time (EWT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum sustainable walk speed (MSWS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood levels of CTAP201 and doxercalciferol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurrence of RV GE
Endpoint domain: Adverse events/effects
Primary endpoint: Change in parental sensitivity
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Early detection of esophageal adenocarcinoma using plasma micro RNAs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Early detection of esophageal adenocarcinoma using plasma messenger RNAs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Therapy response prediction using biomarkers (messenger RNAs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Cmax of Amlodipine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: AUClast of Amlodipine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cmax of Losartan
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: AUClast of Losartan
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cmax of Rosuvastatin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: AUClast of Rosuvastatin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change from Baseline hearing at 8 months post-implantation (hearing gain)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in blood pressure (BP) measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Flow limitation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: glucose intolerance or diabetes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Occurrence of subclinical atrial fibrillation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Lowest Extrapyramidal Symptom Rating Score (ESRS) Total Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: participant recruitment rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: attendance of group exercise classes
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: incidence of patient reported adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: quality of vision
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Development of Functionality
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Postoperative safety within 30 days
Endpoint domain: Adverse events/effects
Primary endpoint: 6-minute walk test (6MWD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of hypoxemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Incidence of MCNS relapse
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of spectacle independence
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Menopause Rating Scale (MRS)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Number of Patients With Severe Toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: Seropositivity Rates for Anti-Wilms Tumor Antigen 1 (WT1) Antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of Patients With Anti-WT1 Antibody Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Declining NFL or decreased rate of increase of NFL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change From Baseline in Oswestry Disability Scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change From Baseline in Numeric Pain Rating Scale
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Percent Fetal Hemoglobin (HbF%) Induction Success Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Prevalence of actinic keratoses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Reported Opioid medication before hospital admission
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Reduction Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adherence Rate to NRT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Implantation rate of frozen/thawed embryos
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Change in weekly walking minutes
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Pancreatic fistula closure ratio after 30 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change from Baseline in Upper extremity section of the Fugl-Meyer Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of Glycosilated Haemoglobin A1c (HbA1c)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Time to diagnosis of FD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients with free respiratory symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Number of adverse events (AE) by severity
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants with Dose-Limiting Toxicities (DLT)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants with disease response
Endpoint domain: Adverse events/effects
Primary endpoint: Days of antimicrobial therapy (DOT) per admission
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: DOT per 1000 patient-days (PD)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Proportion of women with post-delivery hemoglobin ≤ 7.8 gm/dL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Hearing Improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Canadian Occupational Performance Measure (COPM) scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Success of intubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Auditory Brainstem Responses (ABR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of subjects with circulating emboli
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Wrist Flexor Muscle Tone Change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: motor sequelae
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: cognitive sequelae
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: behavioral sequelae
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Frequency and severity of systemic reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Number of subjects with antibody response to the vaccine strain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Antibody response 21 days after the second vaccination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Composite outcome of cardiovascular-related mortality or major cardiovascular event
Endpoint domain: Mortality/survival
Primary endpoint: Time-to-initial abstinence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time-to-lapse
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adequate clinical response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Frequency of HIV Testing
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Reading Aloud Accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Phonology Task Accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Semantics Task Accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Orthography Task Accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perfusion MRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concentration of Substance P in Cerebrospinal Fluid
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Safety of HIV-1 vaccine
Endpoint domain: Adverse events/effects
Primary endpoint: Immunogenicity of HIV-1 vaccine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Incidence of dose limiting or intolerable treatment related adverse events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence, severity and causal relationship of treatment emergent AEs (TEAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of abnormal and clinically relevant safety laboratories
Endpoint domain: Adverse events/effects
Primary endpoint: Fetal presentation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Change in concentration of circulating Prognostic Biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: tumor-to-background count density ratios
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neuropsychological Functioning
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Pathological Complete Response (pCR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of device and procedure related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Arterial oxygen partial pressure (PaO2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Arterial carbon dioxide partial pressure (PaCO2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Lung mechanics
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Number of Participants With Clinically Significant Changes From Baseline in Laboratory Parameter Values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Major device-related complications
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of Tumor Downstaging
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Box and Block Test (affected hand)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Solicited Injection Site and Systemic Reactogenicity
Endpoint domain: Adverse events/effects
Primary endpoint: Study Product-related Serious Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Grade 3 Solicited or Unsolicited Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Progress attaining health goals
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Intraventricular septal thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Renal Clearance of D-chiroinositol (DCI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Level of Circulating D-chiro Inositol (DCI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Caloric content of human milk
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mortality - all cause and cardiovascular
Endpoint domain: Mortality/survival
Primary endpoint: Treatment response mRECIST
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Immunogenicity of tumor-peptide loaded dendritic cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Mean Summed Pain Intensity (SPI) Score Over 24 Hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fistula closure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Metabolic expenditure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Muscle Tone
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Hemoglobin Drop
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Presence versus absence of any myocardial perfusion defect
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Carotid plaque size
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Lower number of arrests
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of positive results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean insufflation pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changing in systolic and diastolic blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: safety of IV injections
Endpoint domain: Adverse events/effects
Primary endpoint: Intervention Rates
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Daily pain evaluations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Utilization of guideline-directed medical therapy
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in treatment volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SPPB Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cognitive skills
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: PROMIS Physical Function items
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Sleep aid assessment
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Change in 6-minute Walk Test Distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy in growing scalp hair
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in non-alcoholic fatty liver disease activity score (NAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Muscle activity of the quadriceps muscles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in Erectile Function Domain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Sexual Encounter Profile (SEP), Question 2
Endpoint domain: Life impact
Endpoint subdomain: Sexual functioning
Primary endpoint: Changes in Sexual Encounter Profile (SEP), Question 3
Endpoint domain: Life impact
Endpoint subdomain: Sexual functioning
Primary endpoint: Speech production skills
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knowledge level regarding malnutrition and self-care
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning